Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Kamada Ltd.

KMDANASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$8.66
$-0.14(-1.59%)
U.S. Market opens in 13h 38m

Kamada Ltd. (KMDA) Stock Overview

Explore Kamada Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap512.2M
P/E Ratio25.50
EPS (TTM)$0.35
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$7.33
3 Months$7.44
1 Year Target$8.95

KMDA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Kamada Ltd. (KMDA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 62.69, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $8.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 25.50 and a market capitalization of 512.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.91%
5-Day Change
-0.22%
1-Month Change
12.12%
3-Month Change
31.56%
6-Month Change
23.68%
Year-to-Date (YTD) Change
26.32%
1-Year Change
22.82%
3-Year Change
101.82%
5-Year Change
35.99%
All-Time (Max) Change
-15.75%

Contact Information

972 8 940 6472
2 Holzman Street, Rehovot, NaN, 7670402

Company Facts

4,200 Employees
IPO DateMay 31, 2013
CountryIL
Actively Trading

Frequently Asked Questions